Heparin Market: By Product, Ultra-low Molecular Weight Heparin, By Application, By Distribution Channel and Geography

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Heparin Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH), By Application (Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and Region

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Heparin Market size was valued at US$ 7,923.7 million in 2023 and is projected to grow at a 2.8% CAGR from 2024 to 2030. Heparin is a naturally occurring glycosaminoglycan, also known as unfractionated heparin (UFH). It is used in medicine as an anticoagulant (blood thinner). It is especially beneficial in the treatment of heart attacks and unstable angina. It is injected into a vein or beneath the skin. Acute coronary syndrome, deep vein thrombosis, pulmonary embolism, and atrial fibrillation are all treated with it, as are cardiopulmonary bypass and hemofiltration during cardiac surgery. It also administers major orthopedic procedures like hip and knee replacements.

Based on the product, the global market is segmented into Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), and Ultra-low Molecular Weight Heparin (ULMWH). The Low Molecular Weight Heparin (LMWH) segment is anticipated to grow at a significant CAGR over the forecast years. Longer and more predictable operation than UFH, as well as easy self-administration at home via subcutaneous injection, which reduces or eliminates hospital stays and eliminates the need for daily blood monitoring, are all important factors driving the market growth. Factors such as increasing advantages of low molecular weight heparin over unfractionated heparin and increasing introduction of biosimilar low molecular weight heparin anticoagulants globally are expected to drive the market growth.

Heparin Market Market Key Developments

  • In April 2021 – Fresenius Kabi launched two new presentations of Heparin Sodium in convenient, ready-to-administer Freeflex IV bags in the U.S.

summary download arrow Download Free Sample

Heparin Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

2.8%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Heparin Market Dynamics

The rise in the prevalence of cardiovascular diseases in key age groups, such as the geriatric population, which is expected to fuel demand for this product, is one of the primary driving factors influencing the global market. Most diseases, including heart attacks, strokes, venous thromboembolism, and cardiovascular conditions like atrial fibrillation, are expected to remain common in the coming years. According to the Centers for Disease Control and Prevention (CDC), approximately 655,000 Americans will die from cardiovascular diseases in 2020. Furthermore, according to 2017 statistics, 18.2 million adults aged 20 and up have coronary artery disease. Such trends and statistics represent significant potential and existing patient populations worldwide; these are just a few factors contributing to the high demand for these products. Furthermore, increasing patient awareness of these drugs' efficacy in treating various heart diseases will drive the market. Due to which, the rising prevalence and incidence of cardiovascular diseases will drive market growth over the forecast period.

Heparin Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 7,923.7 million

Market CAGR

2.8%

By Product Type

  • Unfractionated Heparin
  • Low Molecular Weight Heparin (LMWH)
  • Ultra-low Molecular Weight Heparin (ULMWH)

By Application

  • Venous Thromboembolism
  • Coronary Artery Disease
  • Atrial Fibrillation
  • Others 

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • The Asia Pacific
  • Latin America
  • MEA

Key Features of the Report

  • The  heparin market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The global heparin market size was valued at US$ 7,923.7 million in 2023 and is projected to grow at a 2.8% CAGR from 2024 to 2030.

The market key players are: Baxter International Inc. B. Braun Holding GmbH & Co. KG Dr Reddy's Laboratories Ltd. Fresenius SE & Co KGaA Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Leo Pharma A/S Pfizer Inc. Sanofi SA Teva Pharmaceuticals Viatris Inc.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Heparin Market Introduction 
2.1.Global Heparin Market  - Taxonomy
2.2.Global Heparin Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.Distribution Channel 
2.2.4.Geography
2.2.5.Region
3. Global Heparin Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Heparin Market Analysis, 2019-2023 and Forecast 2024-2030
4.1.  Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Heparin Market  By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
5.1. Unfractionated Heparin
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Low Molecular Weight Heparin (LMWH)
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Ultra-low Molecular Weight Heparin (ULMWH)
5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6. Global Heparin Market  By Application, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
6.1. Venous Thromboembolism
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Coronary Artery Disease
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Atrial Fibrillation
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others 
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7. Global Heparin Market  By Distribution Channel , 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
7.1. Hospital Pharmacies
7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Drug Stores & Retail Pharmacies
7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Heparin Market  By Geography, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. The Asia Pacific
8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Latin America
8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. MEA
8.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. Global Heparin Market  By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
9.1. North America
9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.1.3. Market Opportunity Analysis 
9.2. Europe
9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.2.3. Market Opportunity Analysis 
9.3. Asia Pacific (APAC)
9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.3.3. Market Opportunity Analysis 
9.4. Middle East and Africa (MEA)
9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.4.3. Market Opportunity Analysis 
9.5. Latin America
9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
9.5.3. Market Opportunity Analysis 
10. North America Heparin Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Unfractionated Heparin
10.1.2.Low Molecular Weight Heparin (LMWH)
10.1.3.Ultra-low Molecular Weight Heparin (ULMWH)
10.2.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Venous Thromboembolism
10.2.2.Coronary Artery Disease
10.2.3.Atrial Fibrillation
10.2.4.Others 
10.3.  Distribution Channel  Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospital Pharmacies
10.3.2.Drug Stores & Retail Pharmacies
10.3.3.Online Pharmacies
10.4.  Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.North America
10.4.2.Europe
10.4.3.The Asia Pacific
10.4.4.Latin America
10.4.5.MEA
10.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.5.1.United States of America (USA)
10.5.2.Canada
11. Europe Heparin Market,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
11.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Unfractionated Heparin
11.1.2.Low Molecular Weight Heparin (LMWH)
11.1.3.Ultra-low Molecular Weight Heparin (ULMWH)
11.2.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Venous Thromboembolism
11.2.2.Coronary Artery Disease
11.2.3.Atrial Fibrillation
11.2.4.Others 
11.3.  Distribution Channel  Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospital Pharmacies
11.3.2.Drug Stores & Retail Pharmacies
11.3.3.Online Pharmacies
11.4.  Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.North America
11.4.2.Europe
11.4.3.The Asia Pacific
11.4.4.Latin America
11.4.5.MEA
11.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.5.1.Germany
11.5.2.France
11.5.3.Italy
11.5.4.United Kingdom (UK)
11.5.5.Spain
11.5.6.Rest of EU
12. Asia Pacific (APAC) Heparin Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
12.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Unfractionated Heparin
12.1.2.Low Molecular Weight Heparin (LMWH)
12.1.3.Ultra-low Molecular Weight Heparin (ULMWH)
12.2.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Venous Thromboembolism
12.2.2.Coronary Artery Disease
12.2.3.Atrial Fibrillation
12.2.4.Others 
12.3.  Distribution Channel  Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospital Pharmacies
12.3.2.Drug Stores & Retail Pharmacies
12.3.3.Online Pharmacies
12.4.  Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.North America
12.4.2.Europe
12.4.3.The Asia Pacific
12.4.4.Latin America
12.4.5.MEA
12.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.5.1.China
12.5.2.India
12.5.3.Australia and New Zealand (ANZ)
12.5.4.Japan
12.5.5.Rest of APAC
13. Middle East and Africa (MEA) Heparin Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
13.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Unfractionated Heparin
13.1.2.Low Molecular Weight Heparin (LMWH)
13.1.3.Ultra-low Molecular Weight Heparin (ULMWH)
13.2.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Venous Thromboembolism
13.2.2.Coronary Artery Disease
13.2.3.Atrial Fibrillation
13.2.4.Others 
13.3.  Distribution Channel  Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospital Pharmacies
13.3.2.Drug Stores & Retail Pharmacies
13.3.3.Online Pharmacies
13.4.  Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.North America
13.4.2.Europe
13.4.3.The Asia Pacific
13.4.4.Latin America
13.4.5.MEA
13.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.5.1.GCC Countries
13.5.2.South Africa
13.5.3.Rest of MEA
14. Latin America Heparin Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)
14.1. Product Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.1.1.Unfractionated Heparin
14.1.2.Low Molecular Weight Heparin (LMWH)
14.1.3.Ultra-low Molecular Weight Heparin (ULMWH)
14.2.  Application Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.2.1.Venous Thromboembolism
14.2.2.Coronary Artery Disease
14.2.3.Atrial Fibrillation
14.2.4.Others 
14.3.  Distribution Channel  Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.3.1.Hospital Pharmacies
14.3.2.Drug Stores & Retail Pharmacies
14.3.3.Online Pharmacies
14.4.  Geography Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.4.1.North America
14.4.2.Europe
14.4.3.The Asia Pacific
14.4.4.Latin America
14.4.5.MEA
14.5.  Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14.5.1.Brazil
14.5.2.Mexico
14.5.3.Rest of LA
15. Competition Landscape
15.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
15.2.1.Baxter International Inc.
15.2.2.B. Braun Holding GmbH & Co. KG
15.2.3.Dr Reddy's Laboratories Ltd.
15.2.4.Fresenius SE & Co KGaA
15.2.5.Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
15.2.6.Leo Pharma A/S
15.2.7.Pfizer Inc.
15.2.8.Sanofi SA
15.2.9.Teva Pharmaceuticals
15.2.10.Viatris Inc.
16. Research Methodology 
17. Appendix and Abbreviations 

Key Market Players

  • Baxter International Inc.
  • B. Braun Holding GmbH & Co. KG
  • Dr Reddy's Laboratories Ltd.
  • Fresenius SE & Co KGaA
  • Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
  • Leo Pharma A/S
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceuticals
  • Viatris Inc.

Related Industry Reports

Chronic Refractory Gout Pharmaceuticals Market

Familial Mediterranean Fever Pharmaceuticals Market

Australia Point of Care Diagnostics Market

Aseptic Sampling Market